Literature DB >> 6274469

Features of mammorgraphically negative breast tumours.

C J Cahill, P S Boulter, N M Gibbs, J L Price.   

Abstract

Mammography is a highly sensitive and specific technique in the diagnosis of breast cancer, but some tumours show no radiological features of malignancy. A total of 9.3 per cent of 323 consecutive patients with operable breast cancer had negative mammographic reports, and the clinical radiological and pathological findings in these cases are compared with those in the mammographically diagnosed group. Misinterpretation of carcinoma as a benign lesion and diagnostic difficulties in the dense dysplastic breast were found to be the main causes of error.

Entities:  

Mesh:

Year:  1981        PMID: 6274469     DOI: 10.1002/bjs.1800681215

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

1.  Breast conservation for mammographically occult carcinoma.

Authors:  M Morrow; R A Schmidt; C Bucci
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

2.  Need for open access non-screening mammography in a hospital with a specialist breast clinic service.

Authors:  J J Curtin; M A Sampson
Journal:  BMJ       Date:  1992-02-29

3.  Diagnosing breast carcinoma in young women.

Authors:  A Yelland; M D Graham; P A Trott; H T Ford; R C Coombes; J C Gazet; N G Polson
Journal:  BMJ       Date:  1991-03-16

4.  Invasive breast cancer--the tip of an iceberg.

Authors:  C J Cahill; N M Gibbs; P S Boulter; M J Brient; J L Price
Journal:  Ann R Coll Surg Engl       Date:  1983-11       Impact factor: 1.891

5.  The accuracy of ultrasound in the diagnosis of breast disease.

Authors:  J A Smallwood; P Guyer; K Dewbury; S Mengatti; A Herbert; G T Royle; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1986-01       Impact factor: 1.891

6.  The occurrence of interval cancers in the Nijmegen screening programme.

Authors:  P H Peeters; A L Verbeek; J H Hendriks; R Holland; M Mravunac; G P Vooijs
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.